Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)

This study has been terminated.
(Lack of accrual)
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01532232
First received: February 9, 2012
Last updated: December 22, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)